Results 51 to 60 of about 11,679,175 (389)

COPD and Cardiovascular Disease

Pulmonology, 2019
COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020. COPD and cardiac comorbidities are frequently associated.
André, S., Conde, B., Fragoso, E., Boléo-Tomé, J.P., Areias, Vanda, Cardoso, J.   +5 more
openaire   +7 more sources

Generic versus brand-name drugs used in cardiovascular diseases [PDF]

, 2016
This meta-analysis aimed to compare the efficacy and adverse events, either serious or mild/moderate, of all generic versus brand-name cardiovascular medicines.
Boccia, Stefania, D'Andrea, Elvira, Flacco Maria, Elena, Ioannidis John, Pa, Manzoli, Lamberto, Marzuillo, Carolina, Panic, Nikola, Ricciardi, Walter, Siliquini, Roberta, Villari, Paolo   +9 more
core   +1 more source

NAFLD and cardiovascular diseases: a clinical review

Clinical Research in Cardiology, 2020
Non-alcoholic fatty liver DISEASE (NAFLD) is the most common chronic liver disease in Western countries and affects approximately 25% of the adult population. Since NAFLD is frequently associated with further metabolic comorbidities such as obesity, type
P. Kasper, Anna Martin, S. Lang, F. Kütting, T. Goeser, M. Demir, H. Steffen   +6 more
semanticscholar   +1 more source

Glutathione Participation in the Prevention of Cardiovascular Diseases

Antioxidants, 2021
Cardiovascular diseases (CVD) (such as occlusion of the coronary arteries, hypertensive heart diseases and strokes) are diseases that generate thousands of patients with a high mortality rate worldwide.
D. Matuz-Mares, Héctor Riveros-Rosas, María Magdalena Vilchis-Landeros, H. Vázquez-Meza   +3 more
semanticscholar   +1 more source

Lipoxidation in cardiovascular diseases

Redox Biology, 2019
Lipids can go through lipid peroxidation, an endogenous chain reaction that consists in the oxidative degradation of lipids leading to the generation of a wide variety of highly reactive carbonyl species (RCS), such as short-chain carbonyl derivatives and oxidized truncated phospholipids.
Gianazza, Erica, Brioschi, Maura, Fernandez, Alma Martinez, Banfi, Cristina   +3 more
openaire   +3 more sources

Cutaneous-Pericardial Fistula: Rare Complication of Transapical Aortic Valve Replacement—Case Report and Literature Review

Case Reports in Surgery, 2020
Cutaneous-pericardial fistula is a rare complication of transapical aortic valve replacement; only a few cases are reported in the literature. It is part of a wide range of surgical site infection manifestations that could emerge after surgery.
Andrei Tarus, Mihail Enache, Igor Nedelciuc, Iulian Rotaru, Alberto Emanuel Bacusca, Grigore Tinica   +5 more
doaj   +1 more source

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Clinical Research in Cardiology, 2020
Background Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection.
Bo Li, Jing Yang, Faming Zhao, L. Zhi, Xiqian Wang, Lin Liu, Zhaohui Bi, Yunhe Zhao   +7 more
semanticscholar   +1 more source

C-peptide: a predictor of cardiovascular mortality in subjects with established atherosclerotic disease [PDF]

, 2017
Aim: Insulin resistance and type 2 diabetes are independent risk factors for cardiovascular diseases. Levels of C-peptide are increased in these patients and its role in the atherosclerosis progression was studied in vitro and in vivo over the past ...
Ballanti, Marta, Cardellini, Marina, Cardolini, Iris, Davato, Francesca, Farcomeni, Alessio, Federici, Massimo, Grappasonni, Giulia, Guglielmi, Valeria, Ippoliti, Arnaldo, Menghini, Rossella, Morelli, Monica, Pecchioli, Chiara, Porzio, Ottavia, Rizza, Stefano   +13 more
core   +1 more source

Peri-implant diseases and metabolic syndrome components: a systematic review [PDF]

, 2018
OBJECTIVE: Metabolic syndrome (MetS) is defined as a spectrum of conditions associated with an increased risk of developing CVD and type 2 diabetes.
Letizia, C, Papi, P, Petramala, L, Pilloni, A, Pompa, G, Rosella, D, Saraceno, V   +6 more
core   +1 more source

Long‐Term Survival of Patients With Left Ventricular Noncompaction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background The prognosis of left ventricular noncompaction (LVNC) remains elusive despite its recognition as a clinical entity for >30 years. We sought to identify clinical and imaging characteristics and risk factors for mortality in patients with LVNC.
Vaibhav R. Vaidya, Melissa Lyle, William R. Miranda, Medhat Farwati, Ameesh Isath, Sri Harsha Patlolla, David O. Hodge, Samuel J. Asirvatham, Suraj Kapa, Abhishek J. Deshmukh, Thomas A. Foley, Hector I. Michelena, Heidi M. Connolly, Rowlens M. Melduni   +13 more
doaj   +1 more source